Program ITAPA Health & Care 2025

08:15 - 09:00 Workshop: Breathing Exercises for Better Health (hall Bellevue I.)

08:15

Martina Penxová, instructor

09:00 - 09:35 Our Doctors Abroad: What Slovakia (Doesn't) See (hall Bellevue I.) INTERPRETED

What Slovak doctors working abroad recommend to us. Inspirations, experiences and challenges from abroad. A unique insight into the experiences of Slovak doctors working abroad, a space for dialogue about the inspirations, approaches and challenges they face in the various healthcare systems of the world. How can we use their knowledge and innovations to improve the Slovak healthcare system? Which foreign best practices and new technologies could we implement? How to increase the attractiveness of Slovak healthcare? New perspectives and practical recommendations for the Slovak healthcare system, while providing inspiration for building better quality and more efficient healthcare.

09:00

Michal Kovačič,

Moderator

09:00

Michal Konštacký, doctor, manager and writer living in Switzerland
Peter Lehocký, Klinik Landstraße, Austria - Vienna
Marcela Trnková, general practitioner in Kenilworth, UK

DISCUSSION "Our Doctors Abroad: What Slovakia (Doesn't) See"

9:35 - 10:05 Impact of Legislative Changes on Health Insurers (hall Bellevue I.) INTERPRETED

The partner of the panel is UNION health insurance company.

UZP_logo_zakladne_farebne_0821

09:35

Šimon Jeseňák,

Moderator

09:35

Marian Faktor, Dôvera Health Insurance Company
Dana Rovňákova, General Health Insurance Company
Peter Sloboda, UNION health insurance company

DISCUSSION "Impact of legislative changes on health insurers"

10:05 - 11:05 Human Resources in Healthcare (hall Bellevue I.) INTERPRETED

The staffing crisis in healthcare is a global problem that requires systemic solutions and innovative approaches. How to effectively manage the shortage of health personnel? The discussion will focus on the possibilities of motivating professionals, the use of workers from third countries, the implementation of new models of work organisation and technological solutions. Empowering pharmacists as part of a sustainable healthcare reform will also be a topic. What is the state's plan for the future?

10:05

Šimon Jeseňák,

Moderator

10:05

Peter Szabó, University hospital Martin

TEF - HEALTH Artificial intelligence (AI) and robotics in healthcare as a tool for implementing new technological solutions and motivating human resources

10:12

Jaroslav Kypr, Dr. Max

1on1 interview

10:22

Monika Jankechová, Ministry of Health of Slovak republic
Jaroslav Kypr, Dr. Max
Igor Moravčík, Slovak Chamber of Dentists
Silvia Pekarčíková, Žilina self-governing region
Marián Šóth, Association of Private Physicians of the Slovak Republic

DISCUSSION "Human resources in healthcare"

11:20 - 12:05 Acceleration of telemedicine in Slovak healthcare (hall Bellevue I.) INTERPRETED

How can Slovakia use the potential of telemedicine to transform its health system? The acceleration of telemedicine is becoming a key element of healthcare modernization, especially when it is necessary to respond to the growing demand for fast, efficient, and accessible care. Why should we invest in digitalization and telemedicine? Is this not precisely the way to make quality care available to people in remote areas who otherwise do not have access to specialized services? How can telemedicine change access to prevention, diagnosis, and treatment?

11:20

Michal Kovačič,

Moderator

11:20

Vladimír Dvorový, Slovak Society for Telemedicine and Digital Health
Marian Faktor, DÔVERA Health Insurance Company
Tomáš Švec, Ministry of Health of the Slovak Republic
Michal Rampášek, Faculty of Law, Comenius University in Bratislava

DISCUSSION "Acceleration of telemedicine in Slovak healthcare"

12:05 - 12:35 Medication Policy (hall Bellevue I.) INTERPRETED

The budgetary implications of the policy on medicines are still one of the key challenges of the Slovak healthcare system. What are the consequences of the decategorisation of medicines in Slovakia? How could medicine policy be optimized to ensure sustainable financing and equitable access to necessary patient treatments? New innovative medicines are often costly and require a thorough assessment of their benefits and costs. Are the current mechanisms for financing medicines sufficiently efficient, and how could Slovakia improve its decision-making processes without compromising the sustainability of the health system?